Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

Similar documents
BC Cancer Cervix Screening 2015 Program Results. February 2018

EU guidelines for reporting gynaecological cytology

Clinical Practice Guidelines June 2013

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Cervical Cancer : Pap smear

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Chapter 10: Pap Test Results

Prepared By Jocelyn Palao and Layla Faqih

Gynecologic Cytopathology: Glandular lesions

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)

LGM International, Inc.

Cytology Report Format

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens

Making Sense of Cervical Cancer Screening

CINtec p16 INK4a Staining Atlas

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

ACGME Competency / Milestone Assessment. The Pap Test. Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Pap Reports. Of all women undergoing Papanicolaou (Pap) What Now? Women s Health. What has changed?

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000

Colposcopy. Attila L Major, MD, PhD

Understanding Your Pap Test Results

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Glandular lesions in cervical cytology. Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia

Cervical Precancer: Evaluation and Management

Manitoba Cervical Cancer Screening Program. Operations & Statistical Report and 2006

Cytyc Corporation - Case Presentation Archive - July 2002

Index. Cytoplasm, nonepithelial malignant tumor features 70

Morphology I Slide: 1

Pushing the Boundaries of the Lab Diagnosis in Asia

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

The ABCs of TBS. A Novice's Guide to the Bethesda System

BOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo. Case Discussions. 60 year old woman Routine gynecologic control LBC

International Journal of Health Sciences and Research ISSN:

Case 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow

Cytology and Surgical Pathology of Gynecologic Neoplasms

Histopathology: Cervical HPV and neoplasia

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Cervical Dysplasia and HPV

How invasive cervical cancer audit affects clinical practice

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Cervical Cytology Preparations

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

A cyto-histopathological correlation study of lesions of uterine cervix

Morphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology

chapter 4. The effect of oncogenic HPV on transformation zone epithelium

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

PREVENTION OF CERVICAL CANCER

Management of Abnormal Cervical Cytology and Histology

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

Your Colposcopy Visit

Int. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

Maturation Index 3/29/2017. Disclosure of Relevant Financial Relationships. Gynecologic Cytology. Normal Maturation of Squamous Epithelium : :

Mody. Atypical Glandular Cells(TBS 2001) Adenocarcinoma In Situ(TBS 2001)

January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

Eradicating Mortality from Cervical Cancer

SCOPE OF PRACTICE PGY-5

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

Conflict of Interest 9/7/2018. Dr. Mody 1. None with vendors of cytology equipment/testing/vaccines Amirsys (now Elsevier)

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs

Can LBC Completely Replace Conventional Pap Smear in Developing Countries

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

I have no financial interests to disclose.

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

2003 CytoBase Report

Case year female. Routine Pap smear

CONFRONTING CERVICAL CANCER

Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014

When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?

Video Workshop Cervical cancer screening as a multidisciplinary process

INSCYTE Corporation Suite 403, 2 Berkeley Street, Toronto, Ontario M5A 2W3 Tel: Fax:

Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

Clinically Microscopically Pathogenesis: autoimmune not lifetime

Cytoplasmic changes Nuclear changes

The society for lower genital tract disorders since 1964.

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination

Cervical Conization. 1

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital

Index 179. Genital tract contaminants, 17, 20, 22, 150 papilloma virus-infected cells, 47 squamous cells, sources of, 7

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013

In situ and Invasive Endocervical Carcinoma: Problems and Pitfalls in Diagnosis

Protocol for an integrated data request of test results from the laboratories of pathological anatomy

Cytyc Corporation - Case Presentation Archive - March 2002

Cervical Cancer Screening. David Quinlan December 2013

HPV: cytology and molecular testing

Transcription:

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital

Cervical smear Cervical smear screening can detect LSIL : encompassing CIN I and HPV infections HSIL: encompassing CIN II and III Carcinomas (e.g. squamous cell carcinoma, adenocarcinoma, etc.) Bethesda system is used as the standardized reporting system for cervical smears. Pictures from Robbins Pathological Basis of Diseases

Cervical carcinoma Squamous cell carcinoma Adenocarcinoma Pictures from Robbins Pathological Basis of Diseases

?Picture source: Robbins Pathological Basis of Diseases

Bethesda system (2001) for cervical smear reporting SPECIMEN TYPE: Indicate conventional smear (Pap smear) vs. liquid based vs. other SPECIMEN ADEQUACY GENERAL CATEGORIZATION (optional) Negative Epithelial Cell Abnormality (specify squamous or glandular as appropriate) Other Malignant neoplasms

Bethesda system for cervical smear reporting EPITHELIAL CELL ABNORMALITIES SQUAMOUS CELL Atypical squamous cells of undetermined significance (ASC-US) cannot exclude HSIL (ASC-H) Low grade squamous intraepithelial lesion (LSIL) encompassing: HPV/mild dysplasia/cin 1 High grade squamous intraepithelial lesion (HSIL) encompassing: moderate and severe dysplasia, CIS/CIN 2 and CIN 3 Squamous cell carcinoma GLANDULAR CELL with features suspicious for invasion (if invasion is suspected) Atypical endocervical cells (NOS or specify in comments) endometrial cells (NOS or specify in comments) glandular cells (NOS or specify in comments) Atypical endocervical cells, favor neoplastic glandular cells, favor neoplastic Endocervical adenocarcinoma in situ Adenocarcinoma endocervical endometrial extrauterine not otherwise specified (NOS) OTHER MALIGNANT NEOPLASMS: (specify)

Borderline cellular adquacy X10 objective > 5000 cells/ liquid based slide > or =11 cells/ field Picture here is of borderline cellular adequacy Slide from NCI Bethesda website

Benign endocervical cells Honey comb pattern

Benign endocervical cells Picket-fence pattern and honey comb pattern

Normally shed endometrial cells: N.B. donut shape with outer endometrioid glandular cells and inner core of stromal cells. Usually appear out of tissue plane and degenerated

Cervical smear: low grade squamous intraepithelial lesion (LSIL) Koilocytes - Represent squamous cells with cytopathic changes, characteristically related to HPV effect Koilocytes: Note the enlarged dark smudged nuclei, perinuclear cytoplasmic halo, and condensed cytoplasmic borders Mildly atypical squamous cells with enlarged hyperchromatic nuclei (CIN I)

Cervical smear:high grade squamous intraepithelial lesion (HSIL) HSIL (CIN II) HSIL (CIN III)

Endocervical adenocarcinoma-in situ (AIS)

Squamous cell carcinoma hyperchromatic crowded groups, tumor diathesis (necrosis) SCC with tadpole abnormal cells

HSIL NCI-Bethesda slides

Endoecervical adenocarcinoma

Endometrial adenocarcinoma

Endometrial adenocarcinoma

ASCUS NCI-Bethesda slide

ASCH Slide from NCI-Bethesda

ASC-H

Atypical glandular cells, favour neoplastic (Suspicious of endometrial adenocarcinoma

AGC- mimicker Benign: high endocervical cells Tubal metaplastic cells Brush artifacts Reactive endocervical or endometrial cells Direct endometrial scrapings HSIL (e.g. involving glands)

AGC - A significant proportion may be associated with important diagnosis,e.g. HSIL, AIS or adenocarcinoma - Need colposcopy, further investigation - Try to be more specific if endocervical or endometrial, if one can tells, because this will guide further investigation directions - Try to avoid over-diagnosing AGC.

Potential diagnostic pitfalls Overdiagnosis High sampling Atrophic vaginitis Florid reactive changes and infections (repair, IUCD, viral inclusions ) Radiation effect Fail to recognize mimickers, e.g. Tubal metaplasia, brush artifacts, Arias Stella reaction of pregnancy, endometrial cells (menstrual shed or directly scraped) Underdiagnosis Too few squamous cells, T zone not sampled Pale HSIL Small HSIL litigation cells Obscured background: e.g. too bloody, thick mucus, dried smear Very well differentiated adenocarcinoma (e.g. minimal deviation adenocarcinoma)

Trichomonas infection ( circled) and Tricho Halo (arrrows) - reactive changes in squamous cells

Atropic changes : hyperchromatic naked nuclei but preserved nuclear polarity and fine chromatin Slide from NCI Bethesda website

Reactive endocervical cells Intra-uterine contraceptive device use Sulphur granule (Actinomyces )

Tubal metaplasia Pseudostratified dark nuclei Recognize cilia but not always preserved Note the terminal bar

Reactive cells.

Herpes virus infection Slide from NCI Bethesda website

Radiation effect

Reactive endocervical cells

Quiz cases

Which one is LSIL 2 1 3 Ans:1

Which one is HSIL 1 1 2 Slide from NCI Bethesda website Ans:1

Which is adenocarcinoma? 1 2 Ans:1

Quality assurance Specimen satisfactory rate Ratio of atypical versus definitive positive cases False positives and negatives cytologyhistology correlation - % of high grade lesions (HSIL, ASCH, AIS or >) with histology confirmed - % of histologically confirmed positive cases with false negative cytology diagnosis

Quality Assurance In-house PWH Rescreen all high risk > 10% negative rescreen Periodic review cytotech-pathologist diagnosis discrepancy Cyto-histological correlation Prospective on encounter Retrospective TBM, yearly retrieval of cases External QAP e.g., Hong Kong, Australasia, US Training and continuing educational activities Feedback from clinical colleagues TBM, CPC

Cheers & Thank you